Fig. 1

Cannabidiol (CBD) reduces cell viability in pancreatic cancer cells. (a) Dose response curves representing 48 and 72 h treatment of drugs gemcitabine (a), (c) and CBD (b), (d) in human Panc03.27 and Panc1 cells respectively